Anti Cancer Tablets

Product Details:

Raloxiheal, featuring Raloxifene Hydrochloride Tablets IP 60, is a pharmaceutical marvel known for its efficacy in managing osteoporosis and reducing the risk of invasive breast cancer in postmenopausal women. As a selective estrogen receptor modulator (SERM), Raloxiheal offers a unique mechanism of action by mimicking the beneficial effects of estrogen on bone density while mitigating its adverse effects on the breast and uterus. This medication stands as a testament to modern medicine's commitment to women's health, providing a safe and effective treatment option for two significant health concerns.
For individuals seeking convenient access to Raloxiheal, the option to Buy Raloxifene Hydrochloride Tablets IP 60 online is a game-changer. By adding Raloxifene Hydrochloride Tablets IP 60 to their cart and completing the purchase process online, patients can acquire their medication without the need for frequent visits to physical pharmacies. This streamlined approach to medication procurement ensures timely access to Raloxiheal, allowing individuals to initiate treatment promptly and experience the benefits of therapy sooner.
The efficacy of Raloxiheal lies in its dual action on bone and breast tissue, offering comprehensive protection against osteoporosis and breast cancer. By binding to estrogen receptors in bone, Raloxifene stimulates bone formation and inhibits bone resorption, leading to increased bone mineral density and reduced fracture risk in postmenopausal women with osteoporosis. Simultaneously, Raloxifene blocks estrogen receptors in breast tissue, thereby reducing the proliferation of breast cancer cells and lowering the incidence of invasive breast cancer.
In addition to its role in bone health and breast cancer prevention, Raloxiheal may also offer benefits in cardiovascular health and lipid metabolism. Studies have shown that Raloxifene has favorable effects on lipid profiles, including reducing LDL cholesterol levels and increasing HDL cholesterol levels, which may contribute to its cardioprotective properties. These additional benefits further highlight the multifaceted nature of Raloxiheal and its potential impact on overall health and well-being.
By embracing the option to Buy Raloxifene Hydrochloride Tablets IP 60 online, patients gain access to a convenient and reliable means of obtaining their medication. Online platforms offering Raloxifene Hydrochloride Tablets for purchase ensure authenticity and quality, providing peace of mind to patients and healthcare providers alike. Furthermore, the availability of Raloxiheal online facilitates broader access to this essential medication, particularly for patients residing in remote or underserved areas.
In conclusion, Raloxiheal, featuring Raloxifene Hydrochloride Tablets IP 60, is a groundbreaking medication for the management of osteoporosis and the prevention of invasive breast cancer in postmenopausal women. Through its dual action on bone and breast tissue, Raloxiheal offers comprehensive protection and represents a significant advancement in women's health. By opting to Buy Raloxifene Hydrochloride Tablets IP 60 online, patients can conveniently access this crucial medication and take proactive steps towards better bone health and breast cancer prevention.

Additional Information:

• Delivery Time: 7-8 days in working time .
• Packaging Details: we ship the parcel discreetly

Product Details:

Ralista Tablet is a medicine used in the treatment and prevention of osteoporosis in postmenopausal women. It helps in preventing bone loss that can develop in women after menopause. It makes the bone stronger and lowers the risk of fractures.
Ralista Tablet can be taken with or without food. Take it regularly and do not stop taking the medicine even if you get better until that doctor tells you it is alright to stop. Along with taking the medicine, exercise regularly to strengthen muscles around the affected joint, and manage your weight. You should also avoid smoking and excessive consumption of alcohol while on treatment with this medicine.
The most common side effects of this medicine include hot flashes, leg cramps, peripheral edema, flu-like symptoms, joint pain, and sweating. If any of these side effects do not resolve with time or get worsen, you should let your doctor know. Your doctor may help with ways to reduce or prevent these symptoms by reducing the dose or prescribing an alternative medicine.
To make sure the medicine is safe for you, before taking this medicine, let your doctor know all the other medicines you are taking. Also tell your doctor if you have any problems with your heart, kidneys, or liver. If you are pregnant or breastfeeding, consult your doctor first before taking this medicine.

Additional Information:

• Delivery Time: 7-8 day in working time
• Packaging Details: we ship the parcel discreetly

Product Details:

This medication is used to treat advanced cancer of the colon and rectum. Oxaliplatin is a chemotherapy drug that contains platinum. It is used to slow or stop cancer cell growth.
How to use Oxaliplatin VialRead the Patient Information Leaflet if available from your health care professional before you receive oxaliplatin.
This medication is usually given by infusion into a vein over at least 2 hours by a health care professional. It is usually given every 2 weeks along with other medications (such as 5-fluorouracil and leucovorin). The dosage is based on your medical condition, body size, and response to therapy.

Additional Information:

• Delivery Time: 7-8 day in working time
• Packaging Details: we ship the parcel discreetly

Product Details:

Overview: Ramiven Abemaciclib 150 mg tablets are a cutting-edge pharmaceutical option designed to aid in the treatment of specific types of breast cancer. Abemaciclib, the active ingredient, is an innovative oral medication used in combination with other therapies to target and disrupt the growth of cancer cells. Ramiven is meticulously formulated to offer a precise and effective treatment option for patients seeking to manage their condition and improve their quality of life.

Mechanism of Action: Abemaciclib, the primary component of Ramiven, is a highly selective and potent inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). These proteins play a critical role in the regulation of the cell cycle and cancer cell proliferation. By inhibiting CDK4/6, Ramiven effectively slows down or stops the growth of cancer cells, thereby helping to control the progression of the disease. This targeted approach helps to minimize the impact on normal, healthy cells, offering a more focused treatment regimen.

Indications: Ramiven Abemaciclib is indicated for use in combination with an aromatase inhibitor as an initial endocrine-based therapy for postmenopausal women with HR-positive, HER2-negative breast cancer. It is also used in combination with an endocrine therapy for the treatment of HR-positive, HER2-negative breast cancer that has progressed following prior endocrine therapy. The use of Ramiven is typically determined by healthcare professionals based on individual patient needs and specific cancer characteristics.

Dosage and Administration: The recommended dosage of Ramiven is one 150 mg tablet taken orally twice daily. It is advised to take the tablet at approximately the same times each day to maintain consistent blood levels of the medication. The tablets should be swallowed whole and not chewed or crushed. Dosage adjustments may be necessary based on the patient’s response to treatment and potential side effects. It is essential to follow the healthcare provider's instructions carefully and consult them before making any changes to the dosage.

Side Effects: As with any medication, Ramiven may cause side effects. Common side effects include diarrhea, nausea, vomiting, fatigue, and decreased appetite. More serious adverse effects may include liver enzyme abnormalities and infections. Regular monitoring through blood tests and clinical evaluations is crucial to manage any potential side effects effectively. Patients should report any unusual symptoms or concerns to their healthcare provider promptly.

Precautions: Before starting Ramiven, patients should disclose their full medical history, including any pre-existing liver conditions or other health issues, to their healthcare provider. Women who are pregnant, planning to become pregnant, or breastfeeding should avoid using Ramiven, as its safety during these conditions has not been established. Additionally, interactions with other medications may occur, so it is important to inform the healthcare provider of all current medications and supplements.

Additional Information:

• Delivery Time: 7-8 day in working time
• Packaging Details: we ship the parcel discreetly

Product Details:

Votrient Tablets, which contain the active ingredient Pazopanib, are a prescription medication primarily used in the treatment of certain types of cancer. Pazopanib belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). These medications work by blocking specific enzymes (tyrosine kinases) that are involved in the growth and spread of cancer cells. By inhibiting these enzymes, Votrient helps to stop or slow down the growth of tumors.

Indications:
Votrient is primarily prescribed for the treatment of:

    Advanced Renal Cell Carcinoma (RCC): Votrient is used in the treatment of metastatic or advanced kidney cancer, which is a common and aggressive form of cancer that begins in the kidneys.

    Soft Tissue Sarcoma (STS): Votrient is also indicated for the treatment of certain types of soft tissue sarcomas in patients who have not responded to previous chemotherapy.

The medication has been shown to improve overall survival and progression-free survival in patients with these conditions.

Mechanism of Action:
Votrient works by targeting and blocking the action of proteins known as vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), and c-kit, all of which play a crucial role in the growth of blood vessels (angiogenesis) that supply tumors. By inhibiting these pathways, Votrient effectively reduces the blood supply to tumors, limiting their ability to grow and spread.

In addition to its action on blood vessels, Votrient also interferes with the signals that drive cancer cell proliferation, invasion, and metastasis, further contributing to its therapeutic effects.

Dosage and Administration:
Votrient is typically taken orally in tablet form. The recommended dose for adults with advanced RCC is usually 800 mg once daily, taken on an empty stomach (at least one hour before or two hours after food). For soft tissue sarcoma, the recommended dose may vary based on individual response and tolerance.

Patients should take the medication consistently at the same time each day to help remember to take it. It is important to swallow the tablets whole and avoid crushing or breaking them, as doing so may affect the drug's effectiveness.

Side Effects:
Common side effects of Votrient include fatigue, diarrhea, high blood pressure, nausea, loss of appetite, and changes in liver function. More serious but less common side effects can include liver damage, heart problems, bleeding, and kidney issues.

Patients undergoing treatment with Votrient should be monitored regularly for any changes in liver function, blood pressure, or other signs of complications. In some cases, dose adjustments or discontinuation of therapy may be required.

Warnings and Precautions:
Votrient is not suitable for everyone. People with a history of severe liver disease, heart problems, or recent surgery should consult their healthcare provider before starting treatment. The medication can cause harm to a developing fetus, so it should be avoided during pregnancy. Women who are pregnant or planning to become pregnant should discuss alternative treatment options with their doctor.

Conclusion:
Votrient Tablets are a vital treatment option for individuals with advanced renal cell carcinoma and soft tissue sarcoma. With their ability to target the growth and spread of tumors through the inhibition of specific kinases, Votrient helps to slow disease progression and improve the quality of life for many cancer patients. As with all cancer treatments, the benefits of Votrient must be weighed against its potential side effects, and close medical supervision is essential to ensure optimal outcomes.

Additional Information:

• Delivery Time: Within 7-8 days working.
• Packaging Details: We ship the parcels discreetly.

Product Details:

Aromasin (Exemestane) Tablet is an oral medication primarily used to treat estrogen receptor-positive breast cancer in postmenopausal women. It belongs to a class of drugs known as aromatase inhibitors, which lower estrogen levels in the body by blocking the enzyme aromatase responsible for estrogen production. Reducing estrogen helps slow the growth of hormone-sensitive tumors. Aromasin is commonly prescribed after 2–3 years of tamoxifen therapy to complete a total of 5 years of hormonal treatment or in advanced breast cancer cases. It is taken once daily, usually after a meal, and may cause side effects such as hot flashes, joint pain, and fatigue.

Additional Information:

• Delivery Time: Within 7 to 10 working days

Product Details:

Olaparib (brand name Lynparza) is an oral medication used primarily in the treatment of certain cancers, particularly those associated with BRCA gene mutations. It is a PARP inhibitor, a class of drugs that work by targeting a specific enzyme involved in repairing damaged DNA in cancer cells. By blocking the enzyme poly (ADP-ribose) polymerase (PARP), Olaparib interferes with the cancer cell's ability to repair DNA damage, leading to cell death, particularly in cells already weakened by mutations like those in the BRCA1 or BRCA2 genes.
Indications and Uses

Olaparib is primarily indicated for the treatment of advanced or metastatic cancers in patients with a BRCA1 or BRCA2 mutation, which can include:

    Ovarian cancer: Olaparib is approved for patients with ovarian cancer who have previously received chemotherapy, particularly for those with germline or somatic BRCA mutations.
    Breast cancer: It is used for HER2-negative, BRCA-mutated breast cancer, especially in patients who have received prior treatments and are dealing with advanced disease.
    Pancreatic cancer: Olaparib is used in patients with metastatic pancreatic cancer who have a germline BRCA mutation and have previously been treated with chemotherapy.
Mechanism of Action

Olaparib works by inhibiting the PARP enzyme, which is crucial for repairing single-strand DNA breaks. In cancer cells, especially those with BRCA mutations, the repair mechanism is already compromised, and PARP inhibition further impairs DNA repair, leading to accumulation of DNA damage. This results in the death of cancer cells. Importantly, normal cells, which have functional BRCA proteins, are less affected by the drug, making Olaparib a targeted therapy with the potential for fewer side effects compared to traditional chemotherapy.
Dosage and Administration

Olaparib is typically administered in tablet form, with the standard dose being 400 mg (two 200 mg tablets) taken twice daily, for a total daily dose of 800 mg. The tablets should be taken with or without food, and it's important to follow the dosing schedule provided by the healthcare provider.

The dosage may be adjusted based on the patient’s response to treatment and any side effects. For example, dose reductions may be necessary in the case of severe side effects like anemia, thrombocytopenia, or neutropenia. Regular blood tests are required to monitor blood counts and organ function during treatment.
Side Effects

Like many cancer therapies, Olaparib can cause side effects, though not everyone experiences them. Common side effects include:

    Fatigue: Feeling tired or weak is a frequent complaint among patients.
    Nausea and vomiting: These gastrointestinal symptoms are common but can be managed with supportive care.
    Anemia: A reduction in red blood cell count, leading to fatigue and weakness.
    Neutropenia: Low white blood cell count, which can increase the risk of infections.
    Thrombocytopenia: Low platelet count, which may increase the risk of bleeding or bruising.
    Headache and dizziness are also reported in some patients.

More serious but less common side effects include lung problems, such as shortness of breath or persistent cough, and bone marrow suppression, which could lead to severe anemia or infections.
Precautions and Considerations

    Pregnancy and breastfeeding: Olaparib should not be used during pregnancy or breastfeeding due to potential harm to the developing fetus or infant.
    Liver function: Liver tests should be monitored, as Olaparib can affect liver enzymes in some patients.

Additional Information:

• Delivery Time: Within 7-8 days working.
• Packaging Details: We ship the parcels discreetly.